Work

First report of deschloroketamine (DCK) and 2-fluoro-deschloroketamine (2-FDCK) in oral fluid samples from recreational settings in Brazil

Year: 2026
Type: article
Study design: Observational Study
Abstract: PURPOSE: Ketamine is widely used in recreational settings and is increasingly accompanied by structurally related analogs, including deschloroketamine (DCK) and 2-fluoro-deschloroketamine (2-FDCK). Oral fluid (OF) is a valuable matrix for monitoring recent drug exposure. This study characterized ketamine, its metabolites, and emerging analogs in OF samples from festival and party attendees in Brazil. METHODS: OF samples were collected from volunteers attending 14 festivals and recreational events in Brazil between October-2023 and May-2025. A total of 408 samples positive on initial liquid-liquid extraction-based liquid chromatography-tandem mass spectrometry (LC-MS/MS) screening were subjected to dispersive liquid-liquid microextraction (DLLME) followed by LC-MS/MS to quantify ketamine (KET), norketamine (NORK), 6-hydroxy-norketamine (6-OH-NORK), DCK, and 2-FDCK. RESULTS: Among the 408 screened samples, 198 (48%) were confirmed positive for at least one analyte. Ketamine and 6-OH-NORK were the most frequently detected compounds, followed by NORK. DCK and 2-FDCK were identified in four and two samples, respectively. Positive results were most prevalent among males aged 23-27 years. Only 41% of ketamine-positive participants self-reported ketamine use, and no participant reported intentional use of DCK or 2-FDCK. CONCLUSIONS: To our knowledge, this is the first worldwide report of DCK and 2-FDCK in authentic oral fluid, extending the matrices in which these analogs have been identified and supporting its use as a complementary tool for forensic and public health surveillance of new psychoactive substances.
Language: English
Subfield: Toxicology
Open Access status: hybrid
Estimated APC paid: $2,990
OpenAlex ID: W7236822635
FWCI:
Cites: 34
Cited by:
Related to: 10